Experimental discovery of T-cell epitopes: combining the best of classical and contemporary approaches

References

• Schepers K, Arens R, Schumacher TN. Dissection of cytotoxic and helper T cell responses. Cell. Mol. Life Sci.62(23), 2695–2710 (2005).
   PubMedGoogle Scholar
• Nelson JW. A call to arms: the cytokine selection service. Sci. STKE2001(91), PE2 (2001).
   PubMedGoogle Scholar
• Schulze-Koops H, Kalden JR. The balance of Th1/Th2 cytokines in rheumatoid arthritis. Best Pract. Res. Clin. Rheumatol.15(5), 677–691 (2001).
   PubMed Web of Science ®Google Scholar
• Wodarz D, Jansen VA. The role of T cell help for anti-viral CTL responses. J. Theor. Biol.211(4), 419–432 (2001).
   PubMed Web of Science ®Google Scholar
• Kidd P. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern. Med. Rev.8(3), 223–246 (2003).
   PubMedGoogle Scholar
• Kopec A, Panaszek B, Fal AM. Intracellular signaling pathways in IgE-dependent mast cell activation. Arch. Immunol. Ther. Exp. (Warsz.)54(6), 393–401 (2006).
   PubMedGoogle Scholar
• Simon D, Braathen LR, Simon HU. Anti-interleukin-5 antibody therapy in eosinophilic diseases. Pathobiology72(6), 287–292 (2005).
   PubMed Web of Science ®Google Scholar
• Zhang L and Zhao Y. The regulation of Foxp3 expression in regulatory CD4(+)CD25(+) T cells: multiple pathways on the road. J. Cell. Physiol.211(3), 590–597 (2007).
   PubMedGoogle Scholar
• Loureiro J, Ploegh HL. Antigen presentation and the ubiquitin-proteasome system in host–pathogen interactions. Adv. Immunol.92, 225–305 (2006).
   PubMed Web of Science ®Google Scholar
• Sioud M. An overview of the immune system and technical advances in tumor antigen discovery and validation. Methods Mol. Biol.360, 277–318 (2007).
   PubMedGoogle Scholar
• Takahashi H. Antigen presentation in vaccine development. Comp. Immunol. Microbiol. Infect. Dis.26(5–6), 309–328 (2003).
   PubMedGoogle Scholar
• Shen L, Rock KL. Priming of T cells by exogenous antigen cross-presented on MHC class I molecules. Curr. Opin. Immunol.18(1), 85–91 (2006).
   PubMed Web of Science ®Google Scholar
• Cao K, Hollenbach J, Shi X, Shi W, Chopek M, Fernandez-Vina MA. Analysis of the frequencies of HLA-A, B, and C alleles and haplotypes in the five major ethnic groups of the United States reveals high levels of diversity in these loci and contrasting distribution patterns in these populations. Hum. Immunol.62(9), 1009–1030 (2001).
   PubMed Web of Science ®Google Scholar
• Ovsyannikova IG, Jacobson RM, Poland GA. Variation in vaccine response in normal populations. Pharmacogenomics5(4), 417–427 (2004).
   PubMed Web of Science ®Google Scholar
• Sette A, Sidney J. Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism. Immunogenetics50(3–4), 201–212 (1999).
   PubMed Web of Science ®Google Scholar
• Sylvester-Hvid C, Nielsen M, Lamberth K et al. SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation. Tissue Antigens63(5), 395–400 (2004).
   PubMedGoogle Scholar
• Zeng G, Li Y, El-Gamil M et al. Generation of NY-ESO-1-specific CD4+ and CD8+ T cells by a single peptide with dual MHC class I and class II specificities: a new strategy for vaccine design. Cancer Res.62(13), 3630–3635 (2002).
   PubMed Web of Science ®Google Scholar
• Zwaveling S, Ferreira Mota SC, Nouta J et al. Established human papillomavirus type 16-expressing tumors are effectively eradicated following vaccination with long peptides. J. Immunol.169(1), 350–358 (2002).
   PubMed Web of Science ®Google Scholar
• Valmori D, Levy F, Godefroy E et al. Epitope clustering in regions undergoing efficient proteasomal processing defines immunodominant CTL regions of a tumor antigen. Clin. Immunol.122(2), 163–172 (2007).
   PubMedGoogle Scholar
• Khan AM, Heiny AT, Lee KX et al. Large-scale analysis of antigenic diversity of T-cell epitopes in dengue virus. BMC Bioinformatics7(Suppl. 5), S4 (2006).
   Google Scholar
• van der Burg SH, Bijker MS, Welters MJ, Offringa R, Melief CJ. Improved peptide vaccine strategies, creating synthetic artificial infections to maximize immune efficacy. Adv. Drug Deliv. Rev.58(8), 916–930 (2006).
   PubMed Web of Science ®Google Scholar
• Ali FR, Larche M. Peptide-based immunotherapy: a novel strategy for allergic disease. Expert Rev. Vaccines4(6), 881–889 (2005).
   PubMed Web of Science ®Google Scholar
• Elsawa SF, Rodeberg DA, Celis E. T-cell epitope peptide vaccines. Expert Rev. Vaccines3(5), 563–575 (2004).
   PubMedGoogle Scholar
• Scheibenbogen C, Letsch A, Schmittel A, Asemissen AM, Thiel E, Keilholz U. Rational peptide-based tumour vaccine development and T cell monitoring. Semin. Cancer Biol.13(6), 423–429 (2003).
   PubMed Web of Science ®Google Scholar
• Arnon R, Ben-Yedidia T. Old and new vaccine approaches. Int. Immunopharmacol.3(8), 1195–1204 (2003).
   PubMed Web of Science ®Google Scholar
• Firbas C, Jilma B, Tauber E et al. Immunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) peptide vaccine: a randomized, placebo controlled trial for dose optimization in 128 healthy subjects. Vaccine24(20), 4343–4353 (2006).
   PubMed Web of Science ®Google Scholar
• Suhrbier A. Polytope vaccines for the codelivery of multiple CD8 T-cell epitopes. Expert Rev. Vaccines1(2), 207–213 (2002).
   PubMedGoogle Scholar
• Jones TD, Phillips WJ, Smith BJ et al. Identification and removal of a promiscuous CD4+ T cell epitope from the C1 domain of factor VIII. J. Thromb. Haemost.3(5), 991–1000 (2005).
   PubMed Web of Science ®Google Scholar
• Keilholz U, Martus P, Scheibenbogen C. Immune monitoring of T-cell responses in cancer vaccine development. Clin. Cancer Res.12(7 Pt 2), S2346–S2352 (2006).
   PubMed Web of Science ®Google Scholar
• Wang RF. Tumor antigens discovery: perspectives for cancer therapy. Mol. Med.3(11), 716–731 (1997).
   PubMed Web of Science ®Google Scholar
• Lemmel C, Stevanovic S. The use of HPLC-MS in T-cell epitope identification. Methods29(3), 248–59 (2003).
   PubMed Web of Science ®Google Scholar
• Kessler JH, Beekman NJ, Bres-Vloemans SA et al. Efficient identification of novel HLA-A(*)0201-presented cytotoxic T lymphocyte epitopes in the widely expressed tumor antigen PRAME by proteasome-mediated digestion analysis. J. Exp. Med.193(1), 73–88 (2001).
   PubMed Web of Science ®Google Scholar
• Tenzer S, Peters B, Bulik S et al. Modeling the MHC class I pathway by combining predictions of proteasomal cleavage, TAP transport and MHC class I binding. Cell. Mol. Life Sci.62(9), 1025–1037 (2005).
   PubMed Web of Science ®Google Scholar
• Hakenberg J, Nussbaum AK, Schild H et al. MAPPP: MHC class I antigenic peptide processing prediction. Appl. Bioinformatics2(3), 155–158 (2003).
   PubMedGoogle Scholar
• Weidanz JA, Piazza P, Hickman-Miller H et al. Development and implementation of a direct detection, quantitation and validation system for class I MHC self-peptide epitopes. J. Immunol. Methods318(1–2), 47–58 (2007).
   PubMedGoogle Scholar
• Kern F, Faulhaber N, Frommel C et al. Analysis of CD8 T cell reactivity to cytomegalovirus using protein-spanning pools of overlapping pentadecapeptides. Eur. J. Immunol.30(6), 1676–1682 (2000).
   PubMed Web of Science ®Google Scholar
• Maecker HT, Dunn HS, Suni MA et al. Use of overlapping peptide mixtures as antigens for cytokine flow cytometry. J. Immunol. Methods255(1–2), 27–40 (2001).
   PubMed Web of Science ®Google Scholar
• Tobery TW, Wang S, Wang XM et al. A simple and efficient method for the monitoring of antigen-specific T cell responses using peptide pool arrays in a modified ELISpot assay. J. Immunol. Methods254(1–2), 59–66 (2001).
   PubMedGoogle Scholar
• Lauer GM, Ouchi K, Chung RT et al. Comprehensive analysis of CD8(+)-T-cell responses against hepatitis C virus reveals multiple unpredicted specificities. J. Virol.76(12), 6104–6113 (2002).
   PubMed Web of Science ®Google Scholar
• Day CL, Lauer GM, Robbins GK et al. Broad specificity of virus-specific CD4+ T-helper-cell responses in resolved hepatitis C virus infection. J. Virol.76(24), 12584–12595 (2002).
   PubMed Web of Science ®Google Scholar
• Lauer GM, Barnes E, Lucas M et al. High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection. Gastroenterology127(3), 924–936 (2004).
   PubMedGoogle Scholar
• Zhan X, Hurwitz JL, Brown SA, Slobod KS. HIV-1 envelope T cell epitope “hotspots” among mice and humans and among CD4+ and CD8+ T cell subpopulations. AIDS Res. Hum. Retroviruses23(3), 471–476 (2007).
   PubMedGoogle Scholar
• Nino-Vasquez JJ, Allicotti G, Borras E et al. A powerful combination: the use of positional scanning libraries and biometrical analysis to identify cross-reactive T cell epitopes. Mol. Immunol.40(14–15), 1063–1074 (2004).
   PubMedGoogle Scholar
• Aichinger G, Karlsson L, Jackson MR et al. Major histocompatibility complex class II-dependent unfolding, transport, and degradation of endogenous proteins. J. Biol. Chem.272(46), 29127–29136 (1997).
   PubMedGoogle Scholar
• Abstracts of the 55th Annual Meeting of the American Association for the Study of Liver Diseases. Boston, Massachusetts, USA, October 29–November 2004. Hepatology40(4 Suppl. 1), 162A–771A (2004).
   Google Scholar
• Klade CS, Otava O, Vytvytska O et al. A comprehensive analysis of the T cell response against conserved regions of HCV genotypes 1, 2 and 3. 1(Suppl.), 695A (2004).
   Google Scholar
• Novak EJ, Liu AW, Gebe JA et al. Tetramer-guided epitope mapping: rapid identification and characterization of immunodominant CD4+ T cell epitopes from complex antigens. J. Immunol.166(11), 6665–6670 (2001).
   PubMed Web of Science ®Google Scholar
• Sylvester-Hvid C, Kristensen N, Blicher T et al. Establishment of a quantitative ELISA capable of determining peptide – MHC class I interaction. Tissue Antigens59(4), 251–258 (2002).
   PubMedGoogle Scholar
• Welsh RM, Kim SK, Cornberg M, Clute SC, Selin LK, Naumov YN. The privacy of T cell memory to viruses. Curr. Top. Microbiol. Immunol.311, 117–153 (2006).
   PubMed Web of Science ®Google Scholar
• Singh RA, Rodgers JR, Barry MA. The role of T cell antagonism and original antigenic sin in genetic immunization. J. Immunol.169(12), 6779–6786 (2002).
   PubMed Web of Science ®Google Scholar
• Bachmaier K, Penninger JM. Chlamydia and antigenic mimicry. Curr. Top. Microbiol. Immunol.296, 153–163 (2005).
   PubMed Web of Science ®Google Scholar
• Moutaftsi M, Peters B, Pasquetto V et al. A consensus epitope prediction approach identifies the breadth of murine T(CD8+)-cell responses to vaccinia virus. Nat. Biotechnol.24(7), 817–819 (2006).
   PubMed Web of Science ®Google Scholar
• Peters B, Sette A, Integrating epitope data into the emerging web of biomedical knowledge resources. Nat. Rev. Immunol.7(6), 485–490 (2007).
   PubMed Web of Science ®Google Scholar
• Schellack C, Prinz K, Egyed A et al. IC31, a novel adjuvant signaling via TLR9, induces potent cellular and humoral immune responses. Vaccine24(26), 5461–5472 (2006).
   PubMed Web of Science ®Google Scholar